Researchers say they will be able to detect build up of beta-amyloid and give sufferers a headstart for treatment
Scientists are closer to rolling out a revolutionary blood test for Alzheimer’s after discovering a new way of detecting one of the earliest signs of the brain disease.
For decades scientists worldwide have tried to develop blood tests to predict Alzheimer’s in the hope of replacing the expensive and often invasive brain scans and lumbar punctures currently used to diagnose the most common form of dementia.
At the beginning, we hunted frantically for any medical breakthrough that might hint at a cure. Then hope gave way to the unbearable truth. By Peter Savodnik
One night several years ago, I checked out of a hotel in Cairo and hailed a cab to the airport. It was just after 1am. I had been in Egypt for a week, researching a story on the Muslim Brotherhood, and I had come down with a nasty bug. A blood vessel in my right eye burst, but the doctor said it would probably go away in a few days. I had with me my laptop, a duffel bag crammed with T-shirts, a crushed-velvet blazer, a toothbrush, a razor, medications, an exceptionally tattered copy of Herzog, and an empty, oversized suitcase, which I had been dragging around the world for several weeks and was starting to feel like a vestigial organ. That evening, when my flight landed in Hamburg and I checked into a hotel across the street from the terminal, the woman at the front desk said: “This arrived for you.”
She produced a box that had been shipped from Brussels and loaded it on to a luggage cart. I took it to my room and ripped it open. It was filled with miniature bottles of a yoghurt-like drink that was supposed to cure dementia. I put the bottles in my suitcase, and the next morning I caught my connecting flight to New York.